With the development of society and the improvement of life quality, more than 500 million
people are affected by diabetes. More than 10% of people with diabetes will suffer from …

Cystic fibrosis (CF) is a genetic disease with mutational changes leading to profound
dysbiosis, both pulmonary and intestinal, from a very young age. This dysbiosis plays an …

The lung microbiome is associated with host immune response and health outcomes in
experimental models and patient cohorts. Lung microbiome research is increasing in …

Background While the physical and chemical properties of airborne particulate matter (PM)
have been extensively studied, their associated microbiome remains largely unexplored …

The introduction of mutation-specific combination therapy with the cystic fibrosis
transmembrane conductance regulator (CFTR) modulators elexacaftor/tezacaftor/ivacaftor …

Pseudomonas aeruginosa is one of the most dominant pathogens in cystic fibrosis (CF)
airway disease and contributes to significant inflammation, airway damage, and poorer …

Background The abundance and diversity of antibiotic resistance genes (ARGs) in the
human respiratory microbiome remain poorly characterized. In the context of influenza virus …

Despite over a decade of cystic fibrosis (CF) microbiome research, much remains to be
learned about the overall composition, metabolic activities, and pathogenicity of the …

The development of resistome analysis, ie the comprehensive analysis of antibiotic-
resistance genes (ARGs), is enabling a better understanding of the mechanisms of antibiotic …

Although the cystic fibrosis (CF) lung microbiota has been characterized in several studies,
little is still known about the temporal changes occurring at the whole microbiome level …